Effect of nitric monoxide and carbon monoxide on bFGF stimulated proliferation of vascular smooth muscle cells
Jiang Zhi
Abstract
Jiang Zhi
Abstract
Objective: To investigate the effect of nitric oxide(NO) and carbon monoxide(CO) on proliferation of vascular smooth muscle cells(VSMC) stimulated by basic fibroblast growth factor(bFGF) and their mechanism. Methods: VSMC proliferation was measured by 3H TdR incorporation. Protein phosphorylation, PKC and MAPK activity in VSMC were determined by radioactivity assay. Results: Compared with control, VSMC amplification induced by bFGF was increased by 1.1 fold after 24 h incubation ( P 0.01). Protein phophorylation, PKC and MAPK activities in VSMC were augmented by 38.2%, 1.5 and 2.5 times, respectively ( P 0.01); H L Lys and L Arg had no significant influence on both growth and intracellular protein phosphorylation, PKC and MAPK activities in quiescent VSMC. 5, 10 and 20 μmol·L -1 H L Lys decreased bFGF stimulated VSMC proliferation by 43.4%,46.6% and47.6%,respectively ( P 0.01). Intracellular PKC activities were lowered by 25.6%, 31.8% and 33.9%, respectively ( P 0.01), and MAPK activities were reduced by 15.0%, 25.5% and 40.1%, respectively ( P 0.01); 5, 10 and 20 mmol·L -1 L Arg decreased bFGF stimulated VSMC proliferation by 30.2%, 40.5% and 51.9%, respectively ( P 0.01). Intracellular PKC activities were lowered by 29.8%, 28.9% and 36.6%,respectively ( P 0.01), and MAPK activities were reduced by 19.4%, 32.4% and 44.4%, respectively ( P 0.01). bFGF induced protein phosphorylation in VSMC was inhibited by 10 μmol·L -1 H L Lys and 10 mmol·L -1 L Arg by 31.8% and 37.4%, respectively ( P 0.01). Conclusion: NO and CO may have an inhibitive role against VSMC proliferation caused by bFGF, whose mechanism has a close relationship with inhibition of intracellular protein phosphorylation, PKC and MAPK activities stimulated by bFGF.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of nitric oxide(NO) and carbon monoxide(CO) on proliferation of vascular smooth muscle cells(VSMC) stimulated by basic fibroblast growth factor(bFGF) and their mechanism. Methods: VSMC proliferation was measured by 3H TdR incorporation. Protein phosphorylation, PKC and MAPK activity in VSMC were determined by radioactivity assay. Results: Compared with control, VSMC amplification induced by bFGF was increased by 1.1 fold after 24 h incubation ( P 0.01). Protein phophorylation, PKC and MAPK activities in VSMC were augmented by 38.2%, 1.5 and 2.5 times, respectively ( P 0.01); H L Lys and L Arg had no significant influence on both growth and intracellular protein phosphorylation, PKC and MAPK activities in quiescent VSMC. 5, 10 and 20 μmol·L -1 H L Lys decreased bFGF stimulated VSMC proliferation by 43.4%,46.6% and47.6%,respectively ( P 0.01). Intracellular PKC activities were lowered by 25.6%, 31.8% and 33.9%, respectively ( P 0.01), and MAPK activities were reduced by 15.0%, 25.5% and 40.1%, respectively ( P 0.01); 5, 10 and 20 mmol·L -1 L Arg decreased bFGF stimulated VSMC proliferation by 30.2%, 40.5% and 51.9%, respectively ( P 0.01). Intracellular PKC activities were lowered by 29.8%, 28.9% and 36.6%,respectively ( P 0.01), and MAPK activities were reduced by 19.4%, 32.4% and 44.4%, respectively ( P 0.01). bFGF induced protein phosphorylation in VSMC was inhibited by 10 μmol·L -1 H L Lys and 10 mmol·L -1 L Arg by 31.8% and 37.4%, respectively ( P 0.01). Conclusion: NO and CO may have an inhibitive role against VSMC proliferation caused by bFGF, whose mechanism has a close relationship with inhibition of intracellular protein phosphorylation, PKC and MAPK activities stimulated by bFGF.
Key concepts: Protein kinase C, Vascular smooth muscle, Internal medicine, Intracellular, Endocrinology, Basic fibroblast growth factor, MAPK/ERK pathway, Phosphorylation